Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Current Taxes (2016 - 2020)

Myriad Genetics (MYGN) has disclosed Current Taxes for 7 consecutive years, with $6.1 million as the latest value for Q2 2020.

  • Quarterly Current Taxes rose 103.33% to $6.1 million in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Jun 2020, up 103.33% year-over-year, with the annual reading at $6.1 million for FY2020, 103.33% up from the prior year.
  • Current Taxes for Q2 2020 was $6.1 million at Myriad Genetics, up from $3.5 million in the prior quarter.
  • The five-year high for Current Taxes was $9.8 million in Q3 2018, with the low at $2.3 million in Q1 2016.
  • Average Current Taxes over 5 years is $4.6 million, with a median of $3.6 million recorded in 2019.
  • The sharpest move saw Current Taxes soared 168.75% in 2017, then tumbled 39.44% in 2018.
  • Over 5 years, Current Taxes stood at $3.0 million in 2016, then rose by 6.67% to $3.2 million in 2017, then surged by 53.12% to $4.9 million in 2018, then dropped by 18.37% to $4.0 million in 2019, then skyrocketed by 52.5% to $6.1 million in 2020.
  • According to Business Quant data, Current Taxes over the past three periods came in at $6.1 million, $3.5 million, and $4.0 million for Q2 2020, Q1 2020, and Q4 2019 respectively.